학술논문

Pharmacological Treatment of Anal Fissure: Review of the Literature
Document Type
Journal Article
Source
Nippon Daicho Komonbyo Gakkai Zasshi. 2005, 58(10):830
Subject
Anal fissure
Botulinum toxin
Calcium channel blocker
Glyceryl trinitrate
Pharmacological treatment
カルシウム拮抗薬
ニトログリセリン
ボツリヌス菌毒素
薬物療法
裂肛
Language
English
ISSN
0047-1801
1882-9619
Abstract
With a better understanding of anal fissure pathophysiology since the 1990's, a number of papers have been published regarding the treatment of anal fissure using sphincter relaxants. Pharmacological effects on the internal anal sphincter (smooth muscle) have been well known. Nitric oxide is the principal nonadrenergic, noncholinergic neurotransmitter in the smooth muscle, and its release results in internal anal sphincter relaxation. Internal anal sphincter tone is regulated by increased cytosolic calcium levels and calcium-channel blockers reduce internal anal sphincter tone. Nitroglycerin ointment and other organic nitrate preparations acting as nitric oxide donors lead to decreased resting anal pressure and healing rates of 62-92 percent. However, one drawback of nitric oxide donors is severe headaches. Topical application of calcium channel blockers may be as effective as topical nitrates without the risk of headaches. Locally injected botulinum toxin, which prevents neural transmission by preventing acetylcholine release from presynaptic nerve terminals, showed healing rates of 53-96 percent with a risk of temporary incontinence. There is no evidence of the superiority of the pharmacological treatment compared to lateral internal sphincterotomy.